In this video, Motley Fool health care analyst David Williamson takes us through some of the biggest investing stories in the health care space yesterday. He tells us about Ligand's (NASDAQ:LGND) big FDA win -- and why its relevance may be very short-lived -- and how AVEO Pharmaceuticals (NASDAQ:AVEO) is bouncing back after taking a big hit last week and what's ahead for the company. He also discusses how pharmaceutical giant Pfizer (NYSE:PFE) doesn't always get what it wants.
David Williamson owns shares of Pfizer. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.